Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4929 | 1702 | 42.2 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
78 | 3 | HEPATOCELLULAR CARCINOMA//GASTROENTEROLOGY & HEPATOLOGY//PORTAL HYPERTENSION | 80496 |
627 | 2 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//SORAFENIB | 13826 |
4929 | 1 | SORAFENIB//HEPATOCELLULAR CARCINOMA//HEPATIC ARTERIAL INFUSION CHEMOTHERAPY | 1702 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SORAFENIB | authKW | 2146385 | 28% | 25% | 480 |
2 | HEPATOCELLULAR CARCINOMA | authKW | 702763 | 51% | 4% | 876 |
3 | HEPATIC ARTERIAL INFUSION CHEMOTHERAPY | authKW | 444968 | 3% | 48% | 52 |
4 | ADVANCED HEPATOCELLULAR CARCINOMA | authKW | 394025 | 2% | 61% | 36 |
5 | ADVANCED HCC | authKW | 167423 | 1% | 67% | 14 |
6 | BRIVANIB | authKW | 155230 | 1% | 58% | 15 |
7 | MT SINAI LIVER CANC PROGRAM | address | 137740 | 1% | 32% | 24 |
8 | GIDEON | authKW | 97666 | 0% | 78% | 7 |
9 | HCC TRANSLAT BARCELONA CLIN LIVER CANC GR | address | 89696 | 0% | 100% | 5 |
10 | FDN IRCCS CA GRANDA MAGGIORE HOSP | address | 79906 | 0% | 64% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 18017 | 53% | 0% | 902 |
2 | Gastroenterology & Hepatology | 17141 | 31% | 0% | 520 |
3 | Pharmacology & Pharmacy | 215 | 9% | 0% | 156 |
4 | Surgery | 45 | 5% | 0% | 88 |
5 | Cell Biology | 34 | 5% | 0% | 77 |
6 | Medicine, Research & Experimental | 32 | 3% | 0% | 49 |
7 | Pathology | 17 | 2% | 0% | 28 |
8 | Medicine, General & Internal | 10 | 3% | 0% | 51 |
9 | Radiology, Nuclear Medicine & Medical Imaging | 5 | 2% | 0% | 35 |
10 | Integrative & Complementary Medicine | 1 | 0% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MT SINAI LIVER CANC PROGRAM | 137740 | 1% | 32% | 24 |
2 | HCC TRANSLAT BARCELONA CLIN LIVER CANC GR | 89696 | 0% | 100% | 5 |
3 | FDN IRCCS CA GRANDA MAGGIORE HOSP | 79906 | 0% | 64% | 7 |
4 | BARCELONA CLIN LIVER CANC GRP | 58650 | 1% | 30% | 11 |
5 | GLOBAL MED AFFAIRS PHARMACOVIGILANCE | 53817 | 0% | 100% | 3 |
6 | GASTROINTESTINAL SURG LIVER TRANSPLANTAT UNIT | 42724 | 1% | 26% | 9 |
7 | BCLC GRP | 41704 | 1% | 23% | 10 |
8 | DIPARTIMENTO GASTROENTEROL UO GASTROENTEROL MAL | 40362 | 0% | 75% | 3 |
9 | STATE LIVER DIS | 40362 | 0% | 75% | 3 |
10 | HCC TRANSLAT | 39946 | 0% | 32% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LIVER CANCER | 75502 | 1% | 21% | 20 |
2 | HEPATOLOGY RESEARCH | 11269 | 2% | 2% | 41 |
3 | ONCOLOGY | 10019 | 3% | 1% | 47 |
4 | JOURNAL OF HEPATOLOGY | 6330 | 3% | 1% | 52 |
5 | FUTURE ONCOLOGY | 5075 | 1% | 1% | 20 |
6 | WORLD JOURNAL OF GASTROENTEROLOGY | 4125 | 4% | 0% | 62 |
7 | DIGESTIVE DISEASES | 3689 | 1% | 1% | 19 |
8 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 3472 | 2% | 1% | 38 |
9 | LIVER INTERNATIONAL | 3387 | 1% | 1% | 22 |
10 | ONCOLOGIST | 3212 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SORAFENIB | 2146385 | 28% | 25% | 480 | Search SORAFENIB | Search SORAFENIB |
2 | HEPATOCELLULAR CARCINOMA | 702763 | 51% | 4% | 876 | Search HEPATOCELLULAR+CARCINOMA | Search HEPATOCELLULAR+CARCINOMA |
3 | HEPATIC ARTERIAL INFUSION CHEMOTHERAPY | 444968 | 3% | 48% | 52 | Search HEPATIC+ARTERIAL+INFUSION+CHEMOTHERAPY | Search HEPATIC+ARTERIAL+INFUSION+CHEMOTHERAPY |
4 | ADVANCED HEPATOCELLULAR CARCINOMA | 394025 | 2% | 61% | 36 | Search ADVANCED+HEPATOCELLULAR+CARCINOMA | Search ADVANCED+HEPATOCELLULAR+CARCINOMA |
5 | ADVANCED HCC | 167423 | 1% | 67% | 14 | Search ADVANCED+HCC | Search ADVANCED+HCC |
6 | BRIVANIB | 155230 | 1% | 58% | 15 | Search BRIVANIB | Search BRIVANIB |
7 | GIDEON | 97666 | 0% | 78% | 7 | Search GIDEON | Search GIDEON |
8 | HCC | 57574 | 4% | 5% | 71 | Search HCC | Search HCC |
9 | CHILD PUGH B | 57404 | 0% | 80% | 4 | Search CHILD+PUGH+B | Search CHILD+PUGH+B |
10 | ADVANCED STAGE HEPATOCELLULAR CARCINOMA | 53817 | 0% | 100% | 3 | Search ADVANCED+STAGE+HEPATOCELLULAR+CARCINOMA | Search ADVANCED+STAGE+HEPATOCELLULAR+CARCINOMA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MIYAHARA, K , NOUSO, K , YAMAMOTO, K , (2014) CHEMOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA IN THE SORAFENIB AGE.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 15. P. 4151-4159 | 53 | 68% | 11 |
2 | WHITTAKER, S , MARAIS, R , ZHU, AX , (2010) THE ROLE OF SIGNALING PATHWAYS IN THE DEVELOPMENT AND TREATMENT OF HEPATOCELLULAR CARCINOMA.ONCOGENE. VOL. 29. ISSUE 36. P. 4989 -5005 | 57 | 40% | 361 |
3 | MARKS, EI , YEE, NS , (2016) MOLECULAR GENETICS AND TARGETED THERAPY IN HEPATOCELLULAR CARCINOMA.CURRENT CANCER DRUG TARGETS. VOL. 16. ISSUE 1. P. 53 -70 | 76 | 42% | 1 |
4 | ZHU, AX , (2012) MOLECULARLY TARGETED THERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA IN 2012: CURRENT STATUS AND FUTURE PERSPECTIVES.SEMINARS IN ONCOLOGY. VOL. 39. ISSUE 4. P. 493 -502 | 37 | 82% | 34 |
5 | LLOVET, JM , VILLANUEVA, A , LACHENMAYER, A , FINN, RS , (2015) ADVANCES IN TARGETED THERAPIES FOR HEPATOCELLULAR CARCINOMA IN THE GENOMIC ERA.NATURE REVIEWS CLINICAL ONCOLOGY. VOL. 12. ISSUE 7. P. 408 -424 | 52 | 39% | 42 |
6 | FINN, RS , (2013) EMERGING TARGETED STRATEGIES IN ADVANCED HEPATOCELLULAR CARCINOMA.SEMINARS IN LIVER DISEASE. VOL. 33. ISSUE . P. S11 -S19 | 41 | 73% | 20 |
7 | WORNS, MA , GALLE, PR , (2010) NOVEL INHIBITORS IN DEVELOPMENT FOR HEPATOCELLULAR CARCINOMA.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 19. ISSUE 5. P. 615 -629 | 53 | 61% | 20 |
8 | FORNARO, L , VIVALDI, C , CAPARELLO, C , SACCO, R , ROTELLA, V , MUSETTINI, G , LUCHI, S , BALDINI, EE , FALCONE, A , MASI, G , (2014) DISSECTING SIGNALING PATHWAYS IN HEPATOCELLULAR CARCINOMA: NEW PERSPECTIVES IN MEDICAL THERAPY.FUTURE ONCOLOGY. VOL. 10. ISSUE 2. P. 285 -304 | 49 | 59% | 8 |
9 | CONNELL, LC , HARDING, JJ , ABOU-ALFA, GK , (2016) ADVANCED HEPATOCELLULAR CANCER: THE CURRENT STATE OF FUTURE RESEARCH.CURRENT TREATMENT OPTIONS IN ONCOLOGY. VOL. 17. ISSUE 8. P. - | 49 | 56% | 1 |
10 | BRONTE, F , BRONTE, G , CUSENZA, S , FIORENTINO, E , ROLFO, C , CICERO, G , BRONTE, E , DI MARCO, V , FIRENZE, A , ANGARANO, G , ET AL (2014) TARGETED THERAPIES IN HEPATOCELLULAR CARCINOMA.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 8. P. 966 -974 | 41 | 64% | 12 |
Classes with closest relation at Level 1 |